Delivery Order HHSD200201250430I-75D30122F00006

This federal contract award, valued at $1,072,649.00, was issued by the Centers for Disease Control and Prevention (CDC) to The Vanderbilt University, a leading private research institution. The contract is a delivery order under the Clinical Immunization Safety Assessment (CISA) indefinite delivery vehicle, which supports the CDC's efforts to conduct research and analysis related to vaccine safety. The award does not have a set-aside designation, reflecting Vanderbilt's status as a large...

This is a federal contract award to The Vanderbilt University, a private research university, by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) for CLINICAL EVALUATION LEAD SITE services. The $4,879,802.00 contract is a Delivery Order under the larger Clinical Immunization Safety Assessment (CISA) contract vehicle. The award does not have a set-aside designation. As the prime contractor, Vanderbilt University will provide critical research and...

This is a Cost No Fee Delivery Order contract awarded by the Centers for Disease Control and Prevention (CDC) to Vanderbilt University Medical Center (VUMC) for the 2023 Clinical Immunization Safety Assessment (CISA) Base IDIQ contract. The 5-year contract, with a ceiling value of $6,648,584.00, will provide clinical immunization safety assessment services. VUMC is a prominent academic medical center and nonprofit healthcare provider located in Nashville, Tennessee. The contract does not have...

The Centers for Disease Control and Prevention (CDC) awarded a $874,846.00 Delivery Order contract to Duke University for the 2023 Clinical Immunization Safety Assessment (CISA) Base Indefinite Delivery Indefinite Quantity (IDIQ) contract. This contract, which runs through September 27, 2028, is for the provision of clinical research and immunization safety assessment services. The contract was awarded on a cost-no-fee basis and does not have any set-aside designations. Duke University's...

The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $608,717 delivery order contract to Duke University's Office of Research Administration Division to provide Clinical Immunization Safety Assessment (CISA) services. The contract has a period of performance ending on September 30, 2020 and is not associated with a set-aside. This delivery order is part of a larger CISA indefinite delivery, indefinite quantity (IDIQ) contract with a...

This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to The Trustees of Columbia University in the City of New York, which is doing business as the Health Sciences Division. The $622,892 firm fixed-price delivery order is part of the CDC's Clinical Immunization Safety Assessment (CISA) multiple-award indefinite delivery vehicle (IDV) contract, which has a potential value of $86 million and a period of performance through September 2028. The CISA contract...

The Centers for Disease Control and Prevention (CDC) awarded Duke University a $2,180,450.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract for the 2023 Clinical Immunization Safety Assessment (CISA) base contract. This cost-no-fee delivery order contract will provide clinical research and immunization safety assessment services to the CDC through September 27, 2026. The contract was awarded on an unrestricted basis, without any set-aside designations. As a prime contractor, Duke...

The Centers for Disease Control and Prevention (CDC) has awarded a $300,905 delivery order contract to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, to provide clinical immunization safety assessment (CISA) services. This delivery order is part of a larger $86 million indefinite delivery, indefinite quantity (IDIQ) contract that the CDC previously awarded to Columbia University to support the CISA program through 2028. The CISA...

This firm fixed price contract from the Centers for Disease Control and Prevention (CDC) to Vanderbilt University Medical Center (VUMC) evaluates the effectiveness of vaccines against COVID-19, influenza, and respiratory syncytial virus (RSV) among U.S. adults with severe acute respiratory illness. The $11,908,903.84 potential value contract monitors effectiveness against COVID-19, influenza, and emerging variants, as well as duration of protection. It also conducts RSV surveillance and builds...

The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $900,221 delivery order contract to Childrens Hospital Medical Center, a non-profit healthcare organization in Cincinnati, Ohio. The contract is for the 2023 Clinical Immunization Safety Assessment (CISA) Base Indefinite Delivery, Indefinite Quantity (IDIQ) contract, which supports the CDC's vaccine safety monitoring program. The contract has a period of performance through September 27, 2026. Childrens Hospital Medical...